Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner

Cancer Research

Volumn 65, Issue 23, 2005, Pages 10734-10741

  Gibson, Shannon L ^a   Bindra, Ranjit S ^a   Glazer, Peter M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; PROTEIN SERINE THREONINE KINASE; THREONINE;

APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; CELL ACTIVATION; CELL CYCLE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE CONTROL; HUMAN; HUMAN CELL; HYPOXIA; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SOLID TUMOR; ULTRAVIOLET RADIATION;

APOPTOSIS; CELL CYCLE PROTEINS; CELL HYPOXIA; CELL LINE, TUMOR; DNA DAMAGE; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 28244496609     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1160     Document Type: Article

References (41)

1. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003;3:421-9.
2. Bell DW, Varley JM, Szydlo TE, et al. Heterozygous germ line HCHK2 mutations in Li-Fraumeni syndrome. Science 1999;286:2528-3L
3. Harukj N, Saito H, Tatematsu Y, et al. Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer. Cancer Res 2000;60: 4689-92.
4. Lee SB, Kim SH, Bell DW, et al. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Cancer Res 2001;61:8062-7.
5. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci U S A 2000;97:10389-94.
6. Chaturvedi P, Eng WK, Zhu Y, et al. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 1999;18: 4047-54.
7. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci U S A 1999;96:13777-82.
8. Hirao A, Kong YY, Matsuoka S, et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000;287:1824-7.
9. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 2000;14:289-300.
10. Chehab NH, Malikzay A, Appel M, Halazonetis TD. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev 2000; 14:278-88.
11. Dumaz N, Milne DM, Jardine LJ, Meek DW. Critical roles for the serine 20, but not the serine IS, phosphorylation site and for the polyproline domain in regulating p53 turnover. Biochem J 2001;359:459-64.
12. Mochan TA, Venere M, DiTullio RA, Jr., Halazonetis TD. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res 2003;63:8586-91.
13. Buscemi G, Savio C, Zannini L, et al. Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol 2001;21:5214-22.
14. Wang B, Matsuoka S, Carpenter PB, Elledge SJ. 53BP1, a mediator of the DNA damage checkpoint. Science 2002;298:1435-8.
15. Ward IM, Minn K, van Deursen J, Chen J. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol 2003;23:2S56-63.
16. Foray N, Marot D, Gabriel A, et al. A subset of ATM-and ATR-dependent phosphorylation events requires the BRCA1 protein. EMBO J 2003;22:2860-71.
17. Brown KD, Rathi A, Kamath R, et al. The mismatch repair system is required for S-phase checkpoint activation. Nat Genet 2003;33:80-4.
18. Xu X, Tsvetkov LM, Stern DF. Chk2 activation and phosphorylation- dependent oligomerization. Mol Cell Biol 2002;22:4419-32.
19. Schwarz JK, Lovly CM, Piwnica-Worms H. Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Mol Cancer Res 2003;1: 598-609.
20. Wu X, Cheii J, Autophosphorylation of checkpoint kinase 2 at serine 516 is required for radiation-induced apoptosis. J Biol Chem 2003;278:36163-8.
21. Brizel DM, Scully SP, Harrelson JM, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 1996;56: 5347-50.
22. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous ceil carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
23. Loncaster JA, Harris AL, Davidson SE, et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 2001;61:6394-9.
24. Williams KJ, Cowen RL, Brown LM, Chinje EC, Jaffar M, Stratford IJ. Hypoxia in tumors: molecular targets for anti-cancer therapeutics. Adv Enzyme Regul 2004;44:93-108.
25. Yuan J, Narayanan L, Rockwell S, Glazer PM. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 2000;60:4372-6.
26. Li CY, Little JB, Hu K, et al. Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures. Cancer Res 2001;61:428-32.
27. Paquette B, Little JB. In vivo enhancement of geriomic instability in minisatellite sequences of mouse C3H/10T1/2 cells transformed in vitro by X-rays. Cancer Res 1994;54:3173-8.
28. Mihaylova VT, Bindra RS, Yuan J. et al. Decreased expression of the DNA mismatch repair gene MIM1 under hypoxic stress in mammalian cells. Mol Cell Biol 2003;23:3265-73.
29. Bindra RS, Schaffer PJ, Meng A, et al. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol 2004;24: 8504-18.
30. Koshiji M, To KK, Hammer S. et al. HIF-1α induces genetic instability by transcriptionally down-regulating MutSα expression. Mol Cell 2005;17:793-803.
31. Koi M, Umar A, Chauhan DP, et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces jV-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLHl mutation. Cancer Res 1994;54: 4308-12.
32. Cerosaletti KM, Concannon P. Nibrin forkhead-associated domain and breast cancer C-terminal domain are both required for nuclear focus formation and phosphorylation. J Biol Chem 2003;278: 21944-51.
33. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996;56:5754-7.
34. O'Neill T, Dwyer AJ, Ziv Y, et al. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J Biol Chem 2000;275:22719-27.
35. Kim ST, Lim DS, Canman CE, Kastan MB, Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 1999:274: 37538-43.
36. Casper AM, Nghiem P, Arlt MF, Glover TW. ATR regulates fragile site stability. Cell 2002;111:779-89.
37. Hammond EM, Done MJ, Giaccia AJ. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem 2003;278:12207-13.
38. Hammond EM, Giaccia AJ. The role of ATM and ATR in the cellular response to hypoxia and re-oxygenation. DNA Repair (Amst) 2004;3:1117-22.
39. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Jr., Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a Grphiise checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994;14:6264-77.
40. Hammond EM, Done MJ, Giaccia AJ. Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation. Cancer Res 2004;64:6556-62.
41. DiTullio RA, Jr., Mochan TA, Venere M, et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol 2002;4:998-1002.